Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecas... (osure Systems Features Advantages and Be...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Date:9/14/2010

osure Systems, Features, Advantages and Benefits, 2010 73

Table 58: Interventional Cardiology Devices: Pipeline Products Summary, 2010 74

Table 59: Angioslide eXtra, Product Status, 2010 75

Table 60: F.A.S.T. Funnel Catheter, Product Status, 2010 75

Table 61: CTO Guidewire 0.014, Product Status, 2010 76

Table 62: Safe-Cross RF CTO System-Next Generation, Product Status, 2010 76

Table 63: Variable Control Guidewire System, Product Status, 2010 76

Table 64: Coroflex DEBlue, Product Status, 2010 77

Table 65: PROTEX Coronary Stent System, Product Status, 2010 77

Table 66: JST Drug-Eluting Stent, Product Status, 2010 78

Table 67: XIENCE NANO, Product Status, 2010 78

Table 68: Zylon Zero-Fold Angioplasty Balloon Catheter, Product Status, 2010 78

Table 69: Ostial balloon, Product Status, 2010 79

Table 70: Avion Bifurcation RX2, Product Status, 2010 79

Table 71: CloSys Hemostasis Device, Product Status, 2010 79

Table 72: EpiClose Plus, Product Status, 2010 80

Table 73: Cardiac Catheters, List of Pipeline Products 81

Table 74: Cardiac Catheter, List of Pipeline Products 82

Table 75: Arteriotomy Closure Devices, List of Pipeline Products 82

Table 76: PTCA Balloons, List of Pipeline Products 83

Table 77: Coronary Stents, List of Pipeline Products 84

Table 78: Global Interventional Cardiology Devices Market: Number of Deals by Type, 2002–2009 89

Table 79: Global Interventional Cardiology Devices Market: Deals by Value ($m), 2007–2009 90

1.2 List of FiguresFigure 1: Coronary Heart Disease, Signs and Symptoms, 2010 10

Figure 2: Device Based Treatment Modalities for CHD, 2010 11

Figure 3: Interventional Cardiology Devices, Market Segments, 2010 12

Figure 4: Interventional Cardiology Devices Market, Revenue ($m), Historic, 2002–2009 15

Figure 5: Interventional Cardiology Devi
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine technology :

1. Reportlinker Adds Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs
2. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
3. Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
4. Reportlinker Adds Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
6. Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Pharmaceutical Preparation Manufacturing Industry in the U.S. and Its International Trade [Q3 2010 Edition]
8. Reportlinker Adds US Enzymes Market
9. Reportlinker Adds Trends and Strategies in Pharmaceutical and Medical Device Branding
10. Reportlinker Adds Clinical Trials in China
11. Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

Post Your Comments:

(Date:5/20/2013)... BETHESDA, Md. , May 20, 2013 TNI ... diseases through the activation and mobilization of the body,s ... trading on the OTC Markets, OTCQB marketplace under the ... able to view the real-time Level II stock quotes ... Noreen Griffin , CEO of TNI BioTech, ...

(Date:5/20/2013)... Ill. , May 20, 2013 AbbVie ... initiation of a Phase 3 clinical study called ... assess the effects of the investigational compound atrasentan - ... of kidney disease in patients with stage 2 ... 2 diabetes. SONAR is a large, multinational, double-blind, ...

(Date:5/19/2013)... , May 20, 2013 Whole-cell pertussis vaccines were ... vaccines during a large recent outbreak, according to a ... Whole-cell pertussis vaccines, also called DTwP, were available from ... concerns that ultimately led to the development of acellular ... late 1990s, the United States ...

Breaking Medicine Technology:TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2 TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4

[0] TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace [0] AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy [0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak

... PLYMOUTH MEETING, Pa., Nov. 8, 2011 Health technology ... are the most serious device-related risks, and how can ... nonprofit that researches the best approaches to improving patient ... hospital,s patient safety initiatives with the release of its ...

... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ... and Mental Health Congress, being held November 7 - ... Agitation with Inhaled Loxapine (AZ-004): Responder Analyses in Patients ... by Dr. James V. Cassella, Alexza,s Senior Vice President ...

Cached Medicine Technology:ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 2 ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 3 ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 4 Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 2 Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 3 Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 4 Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 5

ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference

(Date:5/20/2013)... from Comfort & Harmony was featured at ... Association (USLCA) May 2nd – 5th. The conference hosted ... , The USLCA annual conference is a trade ... about the latest trends in lactation. , Mombo ... new mothers use to help support infants while breastfeeding. ...

(Date:5/20/2013)... 2013 Mirena IUD lawsuit ... litigation recently established in U.S. District Court, Southern District ... to court records, the litigation’s first Status Conference was ... Plaintiff’s leadership positions were discussed. So far, at ... District of New York, all of which allege that ...

(Date:5/20/2013)... 2013 Co-founder of Atlanta SEO ... keynote speaker at the 5th International INVEST Domaining & ... brings together company representatives and independent individuals from around ... marketing and investments. , The 2013 conference will take ... México from May 20 to 21. A networking city ...

(Date:5/20/2013)... Nearly 20 percent of kidneys that are recovered ... transplant due to factors ranging from scarring in small ... organ going too long without blood or oxygen. But, ... be "recycled" to help solve the critical shortage of ... Center and colleagues, reporting in the journal Biomaterials ...

(Date:5/20/2013)... 2013 Horizon NJ Health, New Jersey’s ... that it has earned a Commendable Accreditation status ... NJ Health is a wholly owned subsidiary of Horizon ... NCQA Health Plan Accreditation is a nationally recognized program ... health plans provide to their members. Health Plan Accreditation ...

Breaking Medicine News(10 mins):Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2 Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2 Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3 Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2 Health News:Study suggests new source of kidneys for transplant 2 Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2 Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3

[0] Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference [0] Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation [0] EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City [0] Study suggests new source of kidneys for transplant [0] Horizon NJ Health Awarded Commendable Accreditation by NCQA

... ST. LOUIS, Nov. 10 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... previously announced, the Company will be delayed in the ... fiscal 2009. The Company expects to,file a Form 12b-25 ... on Wednesday, November 12, 2008., About KV Pharmaceutical ...

... Left-handed pitcher Jon Lester, who,came back from an off-season ... Boston Red Sox in the 2007 World Series, will ... to a Major League Baseball player,who best exemplifies the ... on and off the field., The 24-year-old Tacoma, ...

... analysis of 33 research projects , , MONDAY, Nov. 10 (HealthDay ... as beta blockers has concluded that they are not useful ... using beta blockers for non-coronary surgery may actually increase the ... conducted the study -- known as a meta-analysis -- recommend ...

... cardiopulmonary bypass does not cause short-term neurological problems ... complex heart defects, according to pediatric researchers. The ... showed adverse neurological effects after newborn surgery for ... news for school-aged children who receive surgery for ...

... 10 A Guide to Implementing,GASB 45, a new issue ... how North Carolina local governments are meeting their,obligations to report ... which is based on a survey of the 30 local ... reports that:, -- 88 percent of the ...

... Net Revenue Increased 93.6% to US$146.5 million; Non-GAAP Gross Margins ... ... 10 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: MR ), a ... selected,unaudited financial results for the third quarter and nine months ended,September ...

KV Pharmaceutical to File Form 12b-25 on November 12, 2008 Red Sox Pitcher Jon Lester Wins 2008 Hutch Award(R)Beta Blocker Use Questioned in Non-Heart Surgery No drop in IQ seen after bypass for child heart surgery A Guide to Implementing GASB 45 Mindray Announces 2008 Third Quarter and Nine Months Results

... Keeler Galilean loupes are ideal ... when increased magnification and a large ... loupes are laser aligned, lightweight and ... ,Fixed working distance and superior depth ...

U tip irrigation-aspiration cannual designed for manual removal of 12 oclock cortex. 23 gauge thin wall irrigation and aspiration lines for maximum aspiration capabilities. Polished finish. Overall l...

... pneumatic stools come with five legs ... of 18" to 25" (total vertical ... hard rubber castors. Comfortable, durable and ... vinyl as standard, other colors available ...

Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....

Medicine Products:

SuperVu Galilean System Vukich Irrigating-Aspirating Cannula Reliance Stools, Model 5340 Anterior Stromal Puncture Cannula, 25 g